![](https://elea.com/wp-content/uploads/REMIVIR_elea.png)
Remivir
Fixed combination of antiretrovirals, nucleoside inhibitors of viral transcriptase Indicated to treat HIV-caused infection or for pre-exposure prophylaxis.
Therapeutic Area
HIV + Infectology
Active Ingredient
Tenofovir + Emtricitabine
Line
Anti-infectives + HIV - Antivirals
Pharmaceutical Form
Coated tablets with Tenofovir DF 300 mg/emtricitabine 200 mg x 30